Search Results - Lode, Holger

Refine Results
  1. 1
    MYCN-targeting vaccines and immunotherapeutics

    MYCN-targeting vaccines and immunotherapeutics by Schramm, Alexander, Lode, Holger

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Functional Bioassays for Immune Monitoring of High-Risk Neuroblastoma Patients Treated with ch14.18/CHO Anti-GD(2) Antibody

    Functional Bioassays for Immune Monitoring of High-Risk Neuroblastoma Patients Treated with ch14.18/CHO Anti-GD(2) Antibody by Siebert, Nikolai, Seidel, Diana, Eger, Christin, Jüttner, Madlen, Lode, Holger N.

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Management of tumor rupture and abdominal compartment syndrome in an infant with bilateral high risk stage 4 neuroblastoma: A case report

    Management of tumor rupture and abdominal compartment syndrome in an infant with bilateral high risk stage 4 neuroblastoma: A case report by Lode, Holger N., Henze, Günter, Siebert, Nikolai, Ehlert, Karoline, Barthlen, Winfried

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma

    Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma by Balicki, Danuta, Reisfeld, Ralph A., Pertl, Ursula, Beutler, Ernest, Lode, Holger N.

    Published 2000
    Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    DNA Vaccination: Using the Patient's Immune System to Overcome Cancer

    DNA Vaccination: Using the Patient's Immune System to Overcome Cancer by Eschenburg, Georg, Stermann, Alexander, Preissner, Robert, Meyer, Hellmuth-Alexander, Lode, Holger N.

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD(2) antibody ch14.18/CHO

    PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD(2) antibody ch14.18/CHO by Siebert, Nikolai, Zumpe, Maxi, Jüttner, Madlen, Troschke-Meurer, Sascha, Lode, Holger N.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    In vitro response of THP-1 derived macrophages to antimicrobially effective PHMB-coated Ti6Al4V alloy implant material with and without contamination with S. epidermidis and P. aeruginosa

    In vitro response of THP-1 derived macrophages to antimicrobially effective PHMB-coated Ti6Al4V alloy implant material with and without contamination with S. epidermidis and P. aer... by Zwicker, Paula, Schmidt, Thomas, Hornschuh, Melanie, Lode, Holger, Kramer, Axel, Müller, Gerald

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    GM‐CSF as successful salvage therapy of metamizole (dipyrone)‐induced agranulocytosis with Fournier's gangrene and severe septic shock in an adolescent

    GM‐CSF as successful salvage therapy of metamizole (dipyrone)‐induced agranulocytosis with Fournier's gangrene and severe septic shock in an adolescent by Winkler, Annegret, Kietz, Silke, Bahlmann, Hagen, Jafarzade, Gunel, Lode, Holger N., Heckmann, Matthias

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice

    Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice by Marx, Madlen, Zumpe, Maxi, Troschke-Meurer, Sascha, Shah, Diana, Lode, Holger N., Siebert, Nikolai

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Nivolumab and dinutuximab beta in two patients with refractory neuroblastoma

    Nivolumab and dinutuximab beta in two patients with refractory neuroblastoma by Ehlert, Karoline, Hansjuergens, Ina, Zinke, Andreas, Otto, Sylke, Siebert, Nikolai, Henze, Guenter, Lode, Holger

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma

    Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma by Lode, Holger N., Dreier, Torsten, Xiang, Rong, Varki, Nissi M., Kang, Angray S., Reisfeld, Ralph A.

    Published 1998
    Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Reduction of CD11b(+) myeloid suppressive cells augments anti-neuroblastoma immune response induced by the anti-GD(2) antibody ch14.18/CHO

    Reduction of CD11b(+) myeloid suppressive cells augments anti-neuroblastoma immune response induced by the anti-GD(2) antibody ch14.18/CHO by Siebert, Nikolai, Zumpe, Maxi, von Lojewski, Leon, Troschke-Meurer, Sascha, Marx, Madlen, Lode, Holger N.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12

    Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12 by Lode, Holger N., Xiang, Rong, Duncan, Steven R., Theofilopoulos, Argyrios N., Gillies, Stephen D., Reisfeld, Ralph A.

    Published 1999
    Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Chronic diseases in pregnant women: prevalence and birth outcomes based on the SNiP-study

    Chronic diseases in pregnant women: prevalence and birth outcomes based on the SNiP-study by Kersten, Ines, Lange, Anja Erika, Haas, Johannes Peter, Fusch, Christoph, Lode, Holger, Hoffmann, Wolfgang, Thyrian, Jochen Rene

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Synergy between an antiangiogenic integrin α(v) antagonist and an antibody–cytokine fusion protein eradicates spontaneous tumor metastases

    Synergy between an antiangiogenic integrin α(v) antagonist and an antibody–cytokine fusion protein eradicates spontaneous tumor metastases by Lode, Holger N., Moehler, Thomas, Xiang, Rong, Jonczyk, Alfred, Gillies, Stephen D., Cheresh, David A., Reisfeld, Ralph A.

    Published 1999
    Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction

    Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction by Lode, Holger N., Xiang, Rong, Pertl, Ursula, Förster, Elisabeth, Schoenberger, Stephen P., Gillies, Stephen D., Reisfeld, Ralph A.

    Published 2000
    Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy

    In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy by Shabat, Doron, Lode, Holger N., Pertl, Ursula, Reisfeld, Ralph A., Rader, Christoph, Lerner, Richard A., Barbas, Carlos F.

    Published 2001
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients

    Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients by Lode, Holger, Siebert, Nikolai, Kietz, Silke, Müller, Ina, Schuster, Manfred, Janzek, Evelyne, Wiederkum, Susanne, Mutschlechner, Oliver, Loibner, Hans

    Published 2013
    Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Generation and Characterization of a Human/Mouse Chimeric GD(2)-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma

    Generation and Characterization of a Human/Mouse Chimeric GD(2)-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma by Eger, Christin, Siebert, Nikolai, Seidel, Diana, Zumpe, Maxi, Jüttner, Madlen, Brandt, Sven, Müller, Hans-Peter, Lode, Holger N.

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    First-line Anti-GD2 Therapy Combined With Consolidation Chemotherapy in 3 Patients With Newly Diagnosed Metastatic Ewing Sarcoma or Ewing-like Sarcoma

    First-line Anti-GD2 Therapy Combined With Consolidation Chemotherapy in 3 Patients With Newly Diagnosed Metastatic Ewing Sarcoma or Ewing-like Sarcoma by Spasov, Neofit J., Dombrowski, Frank, Lode, Holger N., Spasova, Mariya, Ivanova, Liliya, Mumdjiev, Ivan, Burnusuzov, Hassan, Siebert, Nikolai

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: